FDA Inspection
Granules Pharmaceuticals Inc.Granules Pharmaceuticals Inc. – FDA Inspection, Jul 22, 2022
Record Details
This FDA Inspection record concerns Granules Pharmaceuticals Inc., with an inspection on July 22, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 22, 2022
- Product Type
- Drugs
View Company Profile
ID · d7966f15-715b-4405-88ac-c9e7d0d9e64c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1175097
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Granules Pharmaceuticals Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 3, 2026 | VAI | Baltimore District Office | Drug Quality Assurance |
| June 27, 2025 | VAI | Baltimore District Office | Generic Drug Evaluation |
| December 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 21, 2019 | Not classified | Baltimore District Office |
Other documents for Granules Pharmaceuticals Inc.
- FDA Inspection 1311002 - 2026-04-03
- FDA Inspection 1274604 - 2025-06-27
- FDA Inspection 1225087 - 2023-12-15
- FDA Inspection 1215034 - 2023-08-03
- FDA Inspection 1107374 - 2019-08-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.